Removal of pharmaceutical active compounds in wastewater by constructed wetlands: Performance and mechanisms

Performance of an integrated system for the treatment of veterinary hospital wastewaters: assessment of organic load and toxicity levels

Despite its toxic potential, the treatment of wastewaters generated at veterinary hospitals has been neglected. Thus, this is a pioneering study that addresses the treatment of this effluent through an integrated system composed of an upflow anaerobic sludge blanket (UASB), an anoxic filter (AF), an aerobic reactor (AR), a sludge thickener tank (STT) a horizontal flow subsurface constructed wetland (HFSSCW) and a parshall gutter (PG) and with a hydraulic retention time of 10 days. Approximately 5 m³ of wastewater is produced daily, with antibiotics and analgesics being the most commonly used classes of pharmaceutical compounds. Several of the analyzed parameters did not comply with national and international guidelines. In this context, the integrated treatment system demonstrated good results, achieving mean removals of: 98% for COD and 59% for BOD5; 87.5% for Total N and 44% for Total P; 83.8% and 69.9% for DOC and TDC; 95% and 65% for Turbidity and EC; and 78% for TDS. The bioassays with Allium cepa indicated a strong genotoxic potential of the raw wastewater, which was completely eliminated after treatment. Thus, it can be concluded that the integrated treatment system showed promising results regarding the treatment of the investigated wastewaters and can be considered a viable alternative to meet effluent disposal limits established in Brazilian and international standards, as well as significantly reduce their toxic potential.

Phytoremediation of nanoparticles, as future water pollutants, using aquatic and wetland plants: Feasibility, benefits and risks, and research gaps

The widespread use of nanoparticles (NPs) in recent years and their rapid accumulation as potentially dangerous pollutants can lead to significant environmental risks. Different methods are used to eliminate emerging contaminants such as NPs from aquatic environments. Of these methods, phytoremediation using aquatic and wetland plants (WAPs) is considered the most suitable approach because of their extensive root systems, high rates of biomass production, ability to thrive in diverse habitats, and rapid growth within aquatic ecosystems. Various species of genera Lemna, Salvinia, Spirodela, Phragmites, Elodea, and Pistia have been studied for their potential to remediate NPs or contaminants released by NPs. The findings of the review indicate that the majority of WAPs cannot accumulate NPs within their tissues. Nevertheless, the effective methods for removing NPs from the environment by WAPs involve the surface adsorption of NPs onto their roots and the accumulation of pollutants released by NPs within the plant tissues. In addition to the benefits of NPs phytoremediation through WAPs, including sustainability, efficiency, and affordability, there are risks to consider, such as the potential transfer of NPs into the food chain, the release of toxic compounds from NPs due to (bio)degradation, and interactions between contaminated WAPs and other ecosystem components. Furthermore, several research gaps need to be addressed in the future, including a scarcity of field studies, a limited focus on NP types and plant species, unrealistic NP concentration, comparisons with bulk materials, the use of additives and amendments, and the genetic engineering of WAPs.

Implementation of temporal moments to elucidate the reactive transport of metformin and erythromycin in the saturated porous media

This study investigates the fate and transport dynamics of metformin (MTN) and erythromycin (ETM), both classified as pharmaceutical and personal care products (PPCPs), in a saturated sandy soil column using temporal moment analysis (TMA). The key flow and transport parameters, including Darcy velocity, longitudinal dispersivity, adsorption, and degradation coefficients, were analyzed. The results reveal that MTN, a highly mobile contaminant, is eliminated from the column in approximately 40 days, while ETM shows significant adsorption due to its hydrophobic and adsorptive nature. Darcy velocity significantly affects PPCP transport; a one-order magnitude change alters contaminant mass recovery at the column outlet by 88% for MTN and 39-fold for ETM. Longitudinal dispersivity has minimal impact on the transport of PPCPs. However adsorption primarily governs the fate of PPCPs with high adsorption coefficients (Kd), and degradation rates control the fate of low-sorbing PPCPs. A one-order magnitude change in Kd results in a 55% change in the zeroth temporal moment (ZTM) of MTN and a 30-fold change in the case of ETM. Additionally, a one-order magnitude change in the degradation coefficient leads to a 60% variation in MTN's ZTM and a 5% variation in ETM's ZTM. Thus, TMA is a valuable tool for understanding PPCP dynamics in subsurface environments, providing critical insights for managing their increasing concentrations.

Meta-analysis review for pilot and large-scale constructed wetlands: Design parameters, treatment performance, and influencing factors

Despite their longstanding use in environmental remediation, constructed wetlands (CWs) are still topical due to their sustainable and nature-based approach. While research and review publications have grown annually by 7.5 % and 37.6 %, respectively, from 2018 to 2022, a quantitative meta-analysis employing advanced statistics and machine learning to assess CWs has not yet been conducted. Further, traditional statistics of mean ± standard deviation could not convey the extent of confidence or uncertainty in results from CW studies. This study employed a 95 % bootstrap-based confidence interval and out-of-bag Random Forest-based driver analysis on data from 55 studies, totaling 163 cases of pilot and full-scale CWs. The study recommends, with 95 % confidence, median surface hydraulic loading rates (HLR) of 0.14 [0.11, 0.17] m/d for vertical flow-CWs (VF) and 0.13 [0.07, 0.22] m/d for horizontal flow-CWs (HF), and hydraulic retention time (HRT) of 125.14 [48.0, 189.6] h for VF, 72.00 [42.00, 86.28] h for HF, as practical for new CW design. Permutation importance results indicate influent COD impacted primarily on COD removal rate at 21.58 %, followed by HLR (16.03 %), HRT (12.12 %), and substrate height (H) (10.90 %). For TN treatment, influent TN and COD were the most significant contributors at 12.89 % and 10.01 %, respectively, while H (9.76 %), HRT (9.72 %), and HLR (5.87 %) had lower impacts. Surprisingly, while HRT and H had a limited effect on COD removal, they substantially influenced TN. This study sheds light on CWs' performance, design, and control factors, guiding their operation and optimization.

Occurrence and fate of pharmaceutical pollutants in wastewater: Insights on ecotoxicity, health risk, and state-of-the-art removal

Pharmaceutical active compound (PhAC) residues are considered an emerging micropollutant that enters the aquatic environment and causes harmful ecotoxicity. The significant sources of PhACs in the environment include the pharmaceutical industry, hospital streams, and agricultural wastes (animal husbandry). Recent investigations demonstrated that wastewater treatment plants (WWTPs) are an important source of PhACs discharging ecosystems. Several commonly reported that PhACs are detected in a range level from ng L-1 to μg L-1 concentration in WWTP effluents. These compounds can have acute and chronic adverse impacts on natural wildlife, including flora and fauna. The approaches for PhAC removals in WWTPs include bioremediation, adsorption (e.g., biochar, chitosan, and graphene), and advanced oxidation processes (AOPs). Overall, adsorption and AOPs can effectively remove PhACs from wastewater aided by oxidizing radicals. Heterogeneous photocatalysis has also proved to be a sustainable solution. Bioremediation approaches such as membrane bioreactors (MBRs), constructed wetlands (CWs), and microalgal-based systems were applied to minimize pharmaceutical pollution. Noteworthy, applying MBRs has illustrated high removal efficiencies of up to 99%, promising prospective future. However, WWTPs should be combined with advanced solutions, e.g., AOPs/photodegradation, microalgae-bacteria consortia, etc., to treat and minimize their accumulation. More effective and novel technologies (e.g., new generation bioremediation) for PhAC degradation must be investigated and specially designed for a low-cost and full-scale. Investigating green and eco-friendly PhACs with advantages, e.g., low persistence, no bioaccumulation, less or non-toxicity, and environmentally friendly, is also necessary.

Next-generation hybrid technologies for the treatment of pharmaceutical industry effluents

Water and industries are intangible units of the globe that are always set to meet the population's demand. The global population depends on one-third of freshwater increasing the demand. The increase in population along with urbanization has polluted the fresh water resources. The pharmaceutical industry is marked as an emerging contaminant of water pollution. The most common type of pharmaceutical drugs that are detected in the environment includes antibiotics, analgesics, NSAIDs, and pain-relieving drugs. These drugs alter the food chain of the organisms causing chaos mainly in the marine ecosystem. Pharmaceutical drugs are found only in shallow amounts (ng/mg) they have a huge impact on the living system. The consumption of water contaminated with pharmaceutical ingredients can disrupt reproduction, hormonal imbalance, cancer, and respiratory problems. Various methods are used to remove these chemicals from the environment. In this review, we mainly focused on the emerging hybrid technologies and their significance in the effective treatment of pharmaceutical wastewater. This review paper primarily elaborates on the merits and demerits of existing conventional technologies helpful in developing integrated technologies for the modern era of pharmaceutical effluent treatment. This review paper further in detail discusses the various strategies of eco-friendly bioremediation techniques namely biostimulation, bioaugmentation, bacterial degradation, mycoremediation, phytoremediation, and others for the ultimate removal of pharmaceutical contaminants in wastewater. The review makes clear that targeted and hybrid solutions are what the world will require in the future to get rid of these pharmacological prints.

Pharmaceutically active micropollutants: origin, hazards and removal

Pharmaceuticals, recognized for their life-saving potential, have emerged as a concerning class of micropollutants in the environment. Even at minute concentrations, chronic exposure poses a significant threat to ecosystems. Various pharmaceutically active micropollutants (PhAMP), including antibiotics, analgesics, and hormones, have been detected in underground waters, surface waters, seawater, sewage treatment plants, soils, and activated sludges due to the absence of standardized regulations on pharmaceutical discharge. Prolonged exposureof hospital waste and sewage treatment facilities is linked to the presence of antibiotic-resistant bacteria. Conventional water treatment methods prove ineffective, prompting the use of alternative techniques like photolysis, reverse osmosis, UV-degradation, bio-degradation, and nano-filtration. However, commercial implementation faces challenges such as incomplete removal, toxic sludge generation, high costs, and the need for skilled personnel. Research gaps include the need to comprehensively identify and understand various types of pharmaceutically active micropollutants, investigate their long-term ecological impact, develop more sensitive monitoring techniques, and explore integrated treatment approaches. Additionally, there is a gap in understanding the socio-economic implications of pharmaceutical pollution and the efficacy of public awareness campaigns. Future research should delve into alternative strategies like phagotherapy, vaccines, and natural substance substitutes to address the escalating threat of pharmaceutical pollution.

Removal of pharmaceutical contaminants from hospital wastewater using constructed wetlands: a review

AbstractPharmaceutical compounds are a significant source of environmental pollution, particularly in hospital wastewater, which contains high concentrations of such compounds. Constructed wetlands have emerged as a promising approach to removing pharmaceutical compounds from wastewater. This paper aims to review the current state of knowledge on the removal of pharmaceutical compounds from hospital wastewater using constructed wetlands, including the mechanism of removal, removal efficiency, and future prospects. Pharmaceutical contaminants have been considered to be one of the most emerging pollutants in recent years. In this review article, various studies on constructed wetlands are incorporated in order to remove the pharmaceutical contaminants. The nature of constructed wetland can be explained by understanding the types of constructed wetland, characteristics of hospital wastewater, removal mechanism, and removal efficiency. The results of the review indicate that constructed wetlands are effective in removing pharmaceutical compounds from hospital wastewater. The removal mechanism of these compounds involves a combination of physical, chemical, and biological processes, including adsorption, degradation, and uptake by wetland plants. The removal efficiency of constructed wetlands varies depending on several factors, including the type and concentration of pharmaceutical compounds, the design of the wetland system, and the environmental conditions. Further research is necessary to optimize the performance of these systems, particularly in the removal of emerging contaminants, to ensure their effectiveness and long-term sustainability.

Construction of ACNF/Polypyrrole/MIL-100-Fe composites with exceptional removal performance for ceftriaxone and indomethacin inspired by "Ecological Infiltration System"

Developing advanced adsorbents for removing the alarming level of pharmaceuticals active compounds (PhACs) pollution is an urgent task for environmental treatment. Herein, a novel acid-treated carbon nanofiber/polypyrrole/MIL-100-Fe (ACNF/PPy/MIL-100-Fe) with stable 3D-supporting skeleton and hierarchical porous structure had been fabricated to erasure ceftriaxone (CEF) and indomethacin (IDM) from aqueous solution. ACNF as scaffold achieved the highly uniform growth of MIL-100-Fe and PPy. Viewing the large BET surface area (SBET, 999.7 m2/g), highly exposed accessible active sites and copious functional groups, ACNF/PPy/MIL-100-Fe separately showed an excellent adsorption capacity for CEF (294.7 mg/g) and IDM (751.8 mg/g), outstripping the most previously reported adsorbents. Moreover, ACNF/PPy/MIL-100-Fe reached rapid adsorption kinetics and standout reusability property. Further, the redesigned easy-to-recyclable ACF/PPy/MIL-100-Fe inspired by the electrode formation craft achieved prominent adsorption capacity and good reusability property. The adsorption mechanism was evaluated via Fourier transformed infrared spectroscopy (FT-IR) and X-ray photoelectron spectroscopy (XPS). The outcomes revealed that the splendid adsorption capability mainly depended on the electrostatic interactions, hydrogen bonding and π-π interactions. This work sheds light on one facile practical strategy to exploit advanced materials in water environmental remediation.

Pharmaceutical residues in the ecosystem: Antibiotic resistance, health impacts, and removal techniques

Hospital wastewater has emerged as a major category of environmental pollutants over the past two decades, but its prevalence in freshwater is less well documented than other types of contaminants. Due to compound complexity and improper operations, conventional treatment is unable to remove pharmaceuticals from hospital wastewater. Advanced treatment technologies may eliminate pharmaceuticals, but there are still concerns about cost and energy use. There should be a legal and regulatory framework in place to control the flow of hospital wastewater. Here, we review the latest scientific knowledge regarding effective pharmaceutical cleanup strategies and treatment procedures to achieve that goal. Successful treatment techniques are also highlighted, such as pre-treatment or on-site facilities that control hospital wastewater where it is used in hospitals. Due to the prioritization, the regulatory agencies will be able to assess and monitor the concentration of pharmaceutical residues in groundwater, surface water, and drinking water. Based on the data obtained, the conventional WWTPs remove 10-60% of pharmaceutical residues. However, most PhACs are eliminated during the secondary or advanced therapy stages, and an overall elimination rate higher than 90% can be achieved. This review also highlights and compares the suitability of currently used treatment technologies and identifies the merits and demerits of each technology to upgrade the system to tackle future challenges. For this reason, pharmaceutical compound rankings in regulatory agencies should be the subject of prospective studies.

Various species of Basidiomycota fungi reveal different abilities to degrade pharmaceuticals and also different pathways of degradation

The presence of pharmaceuticals (PhACs) in the aquatic environment is an emerging problem worldwide. PhACs reach surface water via the effluents of wastewater treatment plants (WWTPs). WWTPs, although able to remove organic pollutants, do not always remove PhACs. Currently, in the treatment of sewage with the activated sludge method, numerous microorganisms are used, mostly bacteria. Nevertheless, these microorganisms are not resistant to many drug contaminants, and some may also pose a risk to human health. White-rot fungi (WRF), which degrade a wide spectrum of environmental pollutants, may be used as an alternative to microorganisms. However, little data exists comparing the removal of various PhACs by different WRF. In this study, we aimed to determine the ability of three WRF Basidiomycota species, Armillaria mellea, Phanerochaete chrysosporium, and Pleurotus ostreatus, to remove PhACs from various therapeutic groups over the course of 1 h-4 days. Additionally, we identified the fungal metabolites of PhACs, proposed the degradation pathways, and assessed the toxicity of the post-culture media. All selected WRF removed PhACs, but the degree of removal depended on WRF species and PhACs type. Antidepressants and immunosuppressants were removed most efficiently by P. ostreatus, cardiovascular drugs and sulfamethoxazole by A. mellea, and erythromycin by P. chrysosporium. The vast differences observed highlight the need for more intensive testing of different WRF species to select the best species for removing pharmaceuticals of interest. The structure of metabolites generated during degradation strongly depended on WRF species, but the most frequent xenobiotic transformations were oxidation and dealkylation. The obtained results gave insight into the substrate specificity of selected WRF while also providing a broad extension of the knowledge of pharmaceutical degradation by A. mellea.

Designing appropriate site determination criteria for installing constructed wetland treatment system based on multi-criteria decision-making analyses

Constructed wetlands have recently started to be applied as the most important type of nature-based solution against the effects of climate change. This study investigates the determination of the most suitable site determination criteria for the application of this important nature-based solution tool by multiple decision-making methods. For this purpose, first of all, the literature was reviewed and the ten most important criteria for constructed wastelands were determined. Then, fieldwork was carried out according to these determined criteria, and a location was determined in the field according to each criterion. The global positioning system device is used to mark 10 locations that have been determined as waypoints for 10 criteria. The determined waypoints were then scored using the relevant criteria, and the best location was determined using the Multiple Attribute Utility Theory methods. Waypoint 1 received the highest score, 8.4, according to the results. Later, waypoint 7 received a score of 6.2, and waypoint 9 received a score of 5.7.

Insight into pharmaceutical and personal care products removal using constructed wetlands: A comprehensive review

Pharmaceutical and personal care products (PPCPs) were regarded as emerging environmental pollutants due to their ubiquitous appearance and high environmental risks. The wastewater treatment plants (WWTPs) became the hub of PPCPs receiving major sources of PPCPs used by humans. Increasing concern has been focused on promoting cost-effective ways to eliminate PPCPs within WWTPs for blocking their route into the environment through effluent discharging. Among all advanced technologies, constructed wetlands (CWs) with a combination of plants, substrates, and microbes attracted attention due to their cost-effectiveness and easier maintenance during long-term operation. This study offers baseline data for risk control and future treatment by discussing the extent and dispersion of PPCPs in surface waters over the past ten years and identifying the mechanisms of PPCPs removal in CWs based on the up-to-present research, with a special focus on the contribution of sediments, vegetation, and the interactions of microorganisms. The significant role of wetland plants in the removal of PPCPs was detailed discussed in identifying the contribution of direct uptake, adsorption, phytovolatilization, and biodegradation. Meanwhile, the correlation between the physical-chemical characteristics of PPCPs, the configuration operation of wetlands, as well as the environmental conditions with PPCP removal were also further estimated. Finally, the critical issues and knowledge gaps before the real application were addressed followed by promoted future works, which are expected to provide a comprehensive foundation for study on PPCPs elimination utilizing CWs and drive to achieve large-scale applications to treat PPCPs-contaminated surface waters.

Duckweeds for Phytoremediation of Polluted Water

Tiny aquatic plants from the Lemnaceae family, commonly known as duckweeds, are often regarded as detrimental to the environment because of their ability to quickly populate and cover the surfaces of bodies of water. Due to their rapid vegetative propagation, duckweeds have one of the fastest growth rates among flowering plants and can accumulate large amounts of biomass in relatively short time periods. Due to the high yield of valuable biomass and ease of harvest, duckweeds can be used as feedstock for biofuels, animal feed, and other applications. Thanks to their efficient absorption of nitrogen- and phosphate-containing pollutants, duckweeds play an important role in the restorative ecology of water reservoirs. Moreover, compared to other species, duckweed species and ecotypes demonstrate exceptionally high adaptivity to a variety of environmental factors; indeed, duckweeds remove and convert many contaminants, such as nitrogen, into plant biomass. The global distribution of duckweeds and their tolerance of ammonia, heavy metals, other pollutants, and stresses are the major factors highlighting their potential for use in purifying agricultural, municipal, and some industrial wastewater. In summary, duckweeds are a powerful tool for bioremediation that can reduce anthropogenic pollution in aquatic ecosystems and prevent water eutrophication in a simple, inexpensive ecologically friendly way. Here we review the potential for using duckweeds in phytoremediation of several major water pollutants: mineral nitrogen and phosphorus, various organic chemicals, and heavy metals.

An Overview of the Impact of Pharmaceuticals on Aquatic Microbial Communities

Pharmaceuticals are present as pollutants in several ecosystems worldwide. Despite the reduced concentrations at which they are detected, their negative impact on natural biota constitutes a global concern. The consequences of pharmaceuticals' presence in water sources and food have been evaluated with a higher detail for human health. However, although most of the pharmaceuticals detected in the environment had not been designed to act against microorganisms, it is of utmost importance to understand their impact on the environmental native microbiota. Microbial communities can suffer serious consequences from the presence of pharmaceuticals as pollutants in the environment, which may directly impact public health and ecosystem equilibrium. Among this class of pollutants, the ones that have been studied in more detail are antibiotics. This work aims to provide an overview of the impacts of different pharmaceuticals on environmental biofilms, more specifically in biofilms from aquatic ecosystems and engineered water systems. The alterations caused in the biofilm function and characteristics, as well as bacteria antimicrobial tolerance and consequently the associated risks for public health, are also reviewed. Despite the information already available on this topic, the need for additional data urges the assessment of emerging pollutants on microbial communities and the potential public health impacts.